Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of FLUAD versus Vaxigrip in healthy young children previously vaccinated in V70P2
2007-003339-22Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-blind trial of Fluzone Trivalent and influenza vaccine in influenza (2 arms), sponsored by Novartis. Primary endpoint: Overall post-immunization geometric mean titers. Started Aug 2007; status: completed.
02
Drugs
Fluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-003339-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003339-22.